EANM Annual Congress

Philip Kuo, MD, PhD, University of Arizona Cancer Center

Videos

Association Between Baseline PSMA Expression and Response to 177Lu-PSMA-617 Among Patients with Metastatic Castration-Resistant Prostate Cancer

11/10/2023

Philip Kuo , MD, PhD;

Philip Kuo, MD, PhD, shares results from a sub-study of the phase 3 VISION trial, investigating the association between baseline PSMA expression and response to 177Lu-PSMA-617 therapy among patients with metastatic castration-resistant...

Philip Kuo, MD, PhD, shares...

11/10/2023

Oncology

Videos

Identifying Biomarkers to Predict Resistance to Lutetium-177–PSMA-617

10/11/2023

Oliver Sartor , MD;

At the 2023 EANM meeting, Oliver Sartor, MD, discussed identifying biomarkers to predict resistance to Lutetium-177–PSMA-617 using circulating tumor DNA among patients with metastatic castration-resistant prostate cancer.

At the 2023 EANM meeting, Oliver...

10/11/2023

Oncology

EANM Annual Congress

Specialties

Events

Year Round Education

HMP Global Products